Enhanced Assay • Increasing concentration of mitogenic stimulants and longer incubation times significantly increase the cell cycle activation marker CD69. • Increased CD69 expression appears to increase univariate differentiation. • Results demonstrate that multiple parameters can be tuned to optimize assay performance, signal to noise, and maximize differentiation between Alzheimer's disease and other chronic progressive dementia that confound diagnosis.